When no major carryover effects were being present, we analyzed details from both phases with the crossover trial and existing knowledge from the initial period only as a sensitivity analysis. Carryover effects were being shown for that LSAS although not for other outcomes in this trial (VAS, HDRS-17, STAI-S), and https://garrisonf791cff3.ziblogs.com/profile